INNOVATION1 BIOTECH INC. Increase (Decrease) in Accounts Receivable
INNOVATION1 BIOTECH INC. reported Increase (Decrease) in Accounts Receivable of -$7.89 thousand for the 3-month period ending 2023-11-30, per its 10-Q filed 2025-01-27.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2025-01-27
- INNOVATION1 BIOTECH INC. increase (decrease) in accounts receivable for the quarter ending 2023-11-30 was -$7.89K.
- INNOVATION1 BIOTECH INC. increase (decrease) in accounts receivable for the quarter ending 2023-08-31 was $0.00.
- INNOVATION1 BIOTECH INC. increase (decrease) in accounts receivable for the quarter ending 2022-11-30 was $0.00.
- INNOVATION1 BIOTECH INC. increase (decrease) in accounts receivable for the quarter ending 2022-08-31 was $0.00.
- INNOVATION1 BIOTECH INC. increase (decrease) in accounts receivable for fiscal 2023 was $0.00.
- INNOVATION1 BIOTECH INC. increase (decrease) in accounts receivable for fiscal 2022 was -$56.42K.
- INNOVATION1 BIOTECH INC. increase (decrease) in accounts receivable for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- INNOVATION1 BIOTECH INC. increase (decrease) in accounts receivable for fiscal 2019 was $428.00.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2023-11-30 | -$7.89K 10-Q · filed 2025-01-27 | -$7.89K derived: sum of 2 quarters · filed 2025-01-27 | ||
| 2023-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-17 | $0.00 10-K · filed 2024-01-17 | ||
| 2023-05-31 | $0.00 10-Q · filed 2023-09-13 | |||
| 2022-11-30 | $0.00 10-Q · filed 2025-01-27 | $0.00 derived: sum of 2 quarters · filed 2025-01-27 | ||
| 2022-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-17 | -$56.42K 10-K · filed 2024-01-17 | ||
| 2022-05-31 | -$56.42K 10-Q · filed 2023-09-13 | |||
| 2021-11-30 | $0.00 10-Q/A · filed 2022-02-01 | |||
| 2020-11-30 | -$3.08K 10-Q/A · filed 2022-02-01 | -$3.08K derived: sum of 2 quarters · filed 2022-02-01 | ||
| 2020-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-15 | $0.00 10-K · filed 2020-12-15 | ||
| 2020-05-31 | $0.00 10-Q · filed 2020-07-20 | |||
| 2019-11-30 | -$299.00 10-Q · filed 2021-01-13 | $3.42K derived: sum of 2 quarters · filed 2021-01-13 | $3.42K derived: sum of 3 quarters · filed 2021-01-13 | |
| 2019-08-31 | $3.72K derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-15 | $3.72K derived: sum of 2 quarters · filed 2020-12-15 | $428.00 10-K · filed 2020-12-15 | |
| 2019-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-07-20 | -$3.29K 10-Q · filed 2020-07-20 | ||
| 2019-02-28 | -$3.29K 10-Q · filed 2020-04-20 | |||
| 2018-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-17 | -$160.00 derived: sum of 2 quarters · filed 2019-12-17 | -$428.00 10-K · filed 2019-12-17 | |
| 2018-05-31 | -$160.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-07-18 | -$428.00 10-Q · filed 2019-07-18 | ||
| 2018-02-28 | -$268.00 10-Q · filed 2019-04-15 |